- Home » News and EventsPage 11
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility to Increase Biologics Manufacturing Capabilities in Europe
Jul 21, 2021
Catalent today announced that it will commence the first phase of a planned $100 million expansion program at its facility in Anagni, Italy, to add biologics drug substance manufacturing capabilities, supporting the growing European market demand for biologics manufacture and supply.
Catalent Signs Agreement with JOS Pharmaceuticals to Develop Fast-Dissolve Zydis® Formulation for Cannabidiol as an Anesthesia Premedication
Jul 13, 2021
Catalent has signed a development agreement with JOS Pharmaceuticals. Under the agreement, Catalent will undertake a feasibility study for the potential development of a licensed cannabidiol (CBD) product for use as an anesthetic premedication using Catalent’s proprietary Zydis® orally disintegrating tablet (ODT) technology.
Catalent Receives RoSPA Gold Award for Health and Safety Practices
Jun 28, 2021
Catalent today announced that it has been recognized by the Royal Society for the Prevention of Accidents (RoSPA) for demonstrating high health and safety standards.
Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Towards Industrialization of Induced Pluripotent Stem Cell-based Therapies
Jun 24, 2021
Catalent today announced that it has reached an agreement to acquire RheinCell Therapeutics GmbH, a developer and manufacturer of GMP-grade human induced pluripotent stem cells (iPSCs).
Opportunities and Challenges of Clinical Supply Chain Management in China to be Discussed by Catalent Experts at DIA China 2021
May 17, 2021
Experts from Catalent’s clinical supply business will speak at the upcoming DIA China 2021 Conference, being held at the Suzhou International Expo Center, from May 20 – 23.
Catalent Publishes Second Annual Corporate Responsibility Report Highlighting Achievements in an Extraordinary Year for the Pharmaceutical Industry
May 13, 2021
Catalent today published its Corporate Responsibility (CR) Report for fiscal year 2020. The report covers environmental, social, and governance topics relevant to Catalent’s business.
Hofseth BioCare Announces Global Innovation Partnership with Catalent to Develop Delayed-Release Formulation of OmeGo® Fish Oil
May 12, 2021
The partnership will see Catalent use its proprietary OptiGel® DR technology to encapsulate OmeGo, HBC’s unique fish oil derived from sustainable, traceable, and fresh Norwegian Atlantic salmon.
Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing
May 6, 2021
The facility will accommodate Catalent’s new commercial-scale plasmid DNA (pDNA) manufacturing and will provide the opportunity for the immediate growth of Catalent’s pDNA service offering.
Catalent and Stirling Ultracold Announce Partnership to Establish Energy-Efficient Cold Chain Capabilities for Biologics and Emerging Modalities
Apr 29, 2021
Catalent and Stirling Ultracold today announced a partnership whereby Stirling Ultracold becomes the preferred provider of ULT storage across Catalent’s multiple business units.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.